EGEPO-Nasmed Özel Sağlık Hizmetleri Ticaret A.Ş. Ipo
EGEPO-Nasmed Özel Sağlık Hizmetleri Ticaret A.Ş. public offering news has been published! One of the expected public offerings, the company, the public offering analysis of the share that will be offered to the public with the code #EGEPO is as follows;
Nisan 2009’da Egepol Hastanesi ile sağlık sektöründe yerini alan Egepol Sağlık Grubu, 2019 yılında Egepol Cerrahi Hastanesi’ni açmıştır ve 900 çalışanıyla sağlık hizmeti sunmaya devam etmektedir. Yetişkin Yoğun Bakım Üniteleri, Yenidoğan Yoğun Bakım Ünitesi, Kardiyovasküler Cerrahi Yoğun Bakım Ünitesi, Anjiyografi Ünitesi ve 225 yatak kapasitesine sahiptir. Bilimsel gelişmelerin ödünsüz takipçisi, çağdaş teknoloji kullanımında öncü, modern ve temiz mekanlarda kaliteli, hızlı, güvenli, şevkatli, ekonomik ve tıp ahlakına sadık kalarak hastane sözcüğü ile özdeşleşmiş bir kuruluş olarak hizmetlerine devam etmektedir.
EGEPO-Nasmed Özel Sağlık Hizmetleri Ticaret A.Ş. Ipo
EGEPO-Nasmed Özel Sağlık Hizmetleri Ticaret A.Ş. public offering news has been published! One of the expected public offerings, the company, the public offering analysis of the share that will be offered to the public with the code #EGEPO is as follows;

The IPO Table Is As Follows
- Stock Code : EGEPOEGEPO
- Distribution Method : Eşit Dağıtım
- Request Collection Date : 25 Ağustos 2021-26 Ağustos 2021
- Public Offering Price: 5 TL
- Total Lot To Be Released To The Market : 25000000 lots are planned to be released to the market.
- IPO Size: ₺125.000.005,50
- Additional Sale:
- Intermediary Institution: Tacirler Yatırım Menkul Değerler A.Ş.
- Market :
EGEPO Last Year's Financial Statement is as follows;
| 31.12.2023 | 31.12.2022 | 31.12.2021 | |
|---|---|---|---|
| Current Assets | - | - | - |
| Fixed Assets | - | - | - |
| Short Term Liabilities | - | - | - |
| Long Term Liabilities | - | - | - |
| Equities | - | - | - |
| Net Profit/Loss | - | - | - |

EGEPO Cash Ratio
The cash ratio, or cash ratio, is a financial indicator that measures the company's ability to quickly meet its short-term obligations. This is without the need to sell any assets. To calculate the cash ratio, only liquidity and its equivalents are considered in the denominator. Also in the denominator, current liabilities, close are all commitments that must be fulfilled in the future. For example, we mean short-term bank loans (less than one year) and payables to suppliers. Ratio is required to be over 1.00.Cash Ratio Calculator
| 31.12.2023 | 31.12.2022 | 31.12.2021 |
|---|---|---|
| - | - | - |
Nasmed Özel Sağlık Hizmetleri Ticaret A.Ş. Acid-Test Ratio
The acid test, or quick ratio, compares a company's short-term assets to its short-term liabilities to see if a company's short-term liabilities are far above its short-term liabilities. A ratio above 1.00 is desirable.Acid-Test Ratio Calculator
| 31.12.2023 | 31.12.2022 | 31.12.2021 |
|---|---|---|
| - | - | - |
EGEPO Current Ratio
The current ratio, also known as the working capital ratio, measures the ability of a business to meet its short-term obligations that are due within a year. The ratio takes into account the weight of total current assets against total current assets. The ratio is required to be above 1.00.Current Ratio Calculation
| 31.12.2023 | 31.12.2022 | 31.12.2021 |
|---|---|---|
| - | - | - |
Continue reading
Return to other analysis or browse related guide content.